Live News Categoriesequity

PharmaCyte Biotech, Inc. (PMCB) News

Follow PharmaCyte Biotech, Inc. (PMCB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol PMCB Asset equity Sector Markets 90 days 1 Last 0.4011 Updated Sep 14, 2026, 08:12 PM UTC Open live news feed Open PMCB chart & news

L PharmaCyte Biotech 2026: Revenue $0 Net income ($5.79M), EPS ($0.54) — 10-Q Summary PharmaCyte Biotech, Inc. reported results for the 2026 quarter with revenue of $0 and a net loss of ($5.79M), or diluted loss per share of ($0.54), compared with a net loss of ($8.36M) and diluted loss per share of ($1.2 EARNINGS | Sep 14, 2026, 08:12 PM UTC